These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 334187)

  • 21. Trimethoprim/sulfonamide: rational combination therapy.
    Hitchings GH; Singleton SW
    Compr Ther; 1976 May; 2(5):55-63. PubMed ID: 776520
    [No Abstract]   [Full Text] [Related]  

  • 22. Role of thymidine for the activity of trimethoprim, sulfonamides and their combinations.
    Then RL
    Zentralbl Bakteriol A; 1980; 247(4):483-94. PubMed ID: 7006266
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of sulfonamide antagonists on the synergism of sulfamethoxazole-trimethoprim in Escherichia coli.
    Then R
    Zentralbl Bakteriol Orig A; 1973 Oct; 225(1):34-41. PubMed ID: 4148900
    [No Abstract]   [Full Text] [Related]  

  • 24. [New sulfonamide-trimethoprim combination, Supristol. Results of a joint therapeutic trial (author's transl)].
    Frank H; Jurisch H; Kabelitz HJ; Staudacher H; Stoll S; Summa JD; Wagner A
    MMW Munch Med Wochenschr; 1977 Nov; 119(44):1441-4. PubMed ID: 412088
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Sensitivity to sulfamethoxazole-trimethoprim of Escherichia coli isolated from claves (author's transl)].
    Wierup M
    Nord Vet Med; 1974 Nov; 26(11):626-33. PubMed ID: 4615298
    [No Abstract]   [Full Text] [Related]  

  • 26. [Trimethoprim/sulfonamide combinations].
    Adam D
    Med Welt; 1982 Aug; 33(31-32):1105-8. PubMed ID: 6982386
    [No Abstract]   [Full Text] [Related]  

  • 27. [Critical remarks on trimethoprim/sulfonamide combinations in veterinary medicine].
    Löscher W
    Dtsch Tierarztl Wochenschr; 1984 Apr; 91(4):135-9. PubMed ID: 6376046
    [No Abstract]   [Full Text] [Related]  

  • 28. Prevalence and predictors of trimethoprim-sulfamethoxazole resistance among uropathogenic Escherichia coli isolates in Michigan.
    Brown PD; Freeman A; Foxman B
    Clin Infect Dis; 2002 Apr; 34(8):1061-6. PubMed ID: 11914994
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Kinetics and mechanisms of action of 'folate synthesis inhibitors', alone or in combination, on Escherichia coli. III. Pyrimethamine, trimethoprim and sulfamethoxazole.
    Seydel JK; Wempe E
    Chemotherapy; 1975; 21(3-4):131-45. PubMed ID: 1098865
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synergistic antibacterial activity in vitro of trimethoprim and sulphonamides and the importance of pharmacokinetic properties for optimal therapy.
    Seydel JK; Wempe E
    Infection; 1979; 7 Suppl 4():S313-20. PubMed ID: 389807
    [No Abstract]   [Full Text] [Related]  

  • 31. [Clinical trial of the antibacterial combination sulfamoxole/trimethoprim (CN 3123). 1st communication. Efficacy activity spectrum--resistance in therapy (author's transl)].
    Etzel M; Wesenberg W
    Arzneimittelforschung; 1976; 26(42):661-5. PubMed ID: 782474
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetics of sulphadiazine, sulphamethoxazole and trimethoprim in patients with varying renal function.
    Bergan T; Brodwall EK; Vik-Mo H; Anstad U
    Infection; 1979; 7 Suppl 4():S382-7. PubMed ID: 511352
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sulphonamides and trimethoprim.
    Reeves D
    Lancet; 1982 Aug; 2(8294):370-3. PubMed ID: 6124767
    [No Abstract]   [Full Text] [Related]  

  • 34. Quantification of the antibacterial action of trimethoprim alone and in combination with sulfonamides by bacterial growth kinetics.
    Seydel JK; Wempe E; Miller GH; Miller L
    J Infect Dis; 1973 Nov; 128():Suppl:463-9 p. PubMed ID: 4585952
    [No Abstract]   [Full Text] [Related]  

  • 35. The pharmacokinetics of trimethoprim and trimethoprim/sulphonamide combinations, including penetration into body tissues.
    Reeves DS; Wilkinson PJ
    Infection; 1979; 7 Suppl 4():S330-41. PubMed ID: 389810
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Do sulphonamide-trimethoprim combinations select less resistance to trimethoprim than the use of trimethoprim alone?
    Lacey RW
    J Med Microbiol; 1982 Nov; 15(4):403-27. PubMed ID: 6294297
    [No Abstract]   [Full Text] [Related]  

  • 37. Is the ultrastructural damage caused by subinhibitory concentrations of trimethoprim and sulphadiazine part of their normal mechanism of action?
    Richards RM; Eumkeb G; Marshall D
    Microbios; 1997; 92(372-373):183-97. PubMed ID: 9670550
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Activity and interaction of trimethoprim and sulphamethoxazole against Escherichia coli.
    Greenwood D; O'Grady F
    J Clin Pathol; 1976 Feb; 29(2):162-6. PubMed ID: 777036
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The use of sulfonamide containing drug combinations in pyogenic processes of the maxillofacial region].
    Fassauer H; Bethmann W; Fassauer HM; Epperlein I
    Stomatol DDR; 1979 Sep; 29(9):684-92. PubMed ID: 293072
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetics and Safety of Sulfamethoxazole-Trimethoprim After Oral Administration of Single and Multiple Doses to Rhode Island Red Chickens (
    Petritz OA; Enomoto H; Meyer EG; Thomson A; Baynes RE; Flammer K
    J Avian Med Surg; 2023 Jun; 37(1):1-12. PubMed ID: 37358198
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.